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1. Purpose 
 
With the established BioBrick Assembly standards, fusion proteins with diversified 
functions are easy to manipulate. However, we realized that the existing BBF RFC do not 
clearly defining the standard for peptide display on BioBrick proteins. Considering the 
promising use of specific small peptide modification on functional proteins, targeting to 
specific cell types, for example, we proposed a standard for small peptide modification 
on BioBrick proteins. 
 
2. Relation to other BBF RFCs 
 
This BBF RFC extends BBF RFC 10 and BBF RFC 25. For fusion proteins of large 
segments, BBF RFC 37 is recommended. 
 
3. Copyright Notice 
 
Copyright (C) The BioBricks Foundation (2009). All Rights Reserved. 
 
 
 
 
 
 
4. Definition 
4.1 Small Peptide Sequences 
Small peptide sequences are defined as the peptide sequences that are smaller than 50 bp. 
 
4.2 Definitive Peptides 
Definitive peptides are the peptide with known sequences. They are also RECOMMEND 
to have known functions. 
 
4.3 Randomized Peptides 
Randomized peptides are the peptide with randomized sequences, which are often 
generated for large-scale screening of peptides with desired specificity. 
 
4.4 Interchangeable Peptides 
Peptides with standardized prefix and suffix for protein fusion that can be replaced by 
other Biobricks that also accords this standard. 
 
5. Motivation 
As for peptides displayed onto the BioBrick proteins, they should be easier to be changed 
to meet different specificity. Some peptides, such as those generated by phage display, 
are relatively hard to be incorporated onto the existing BioBrick protein due to their small 
encoding sequences. Researchers can modify the desired BioBrick protein via PCR 
amplification of their original sequence(s). 
 
 
 
 
 
 
 
Figure.1 Original Procedure for Small Peptide Modification on BioBrick Proteins 
Original Sequence 
EcoRI NotI XbaI SpeI NotI PstI Part 
However, when researchers want a certain BioBrick Protein to be modified by a large 
variety of small peptides, either definitive or randomized, the original procedure will not 
be easy to manipulate. 
 
Thus, we designed the standards for large-scale peptide sequence modification regarding 
both definitive and randomized sequences. 
 
6. Definitive Peptide Sequence Modification 
When dealing with large-scale definitive peptide modification, researchers are 
RECOMMENDED to firstly make a “Mother Part” without any peptide modification. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.2 Standardized Procedure for Definitive Small Peptide Modification on BioBrick 
Proteins 
 
 
Original Sequence 
EcoRI NotI XbaI SpeI NotI PstI Mother Part 
EcoRI NotI XbaI SpeI NotI PstI Daughter Part 
EcoRI NotI XbaI SpeI NotI PstI Daughter Part 
EcoRI NotI XbaI SpeI NotI PstI Daughter Part 
According to BBF RFC 25, Biobricks for protein fusion MUST contain NgoMIV as the 
prefix and AgeI as the suffix. The construction of Mother Parts MUST also contains 
NgoMIV as the prefix and AgeI as the suffix if they are supposed for protein fusion. 
 
7. Randomized Peptide Sequence Modification 
As for randomized peptides for large-scale specificity screening, the peptide sequences 
are RECOMMEND to be incorporated into the BioBrick protein as the following 
standards. 
 
For BioBricks that will not experience further fusion, peptide sequences should be 
randomly generated as: 
                                                    AgeI                       AgeI 
5’-ACCGGT (NNN)n ACCGGT -3’ 
When the peptides are supposed to modify the upstream region of the Mother Part, 
                                                  NgoMIV                NgoMIV 
5’-GCCGGC (NNN)n GCCGGC-3’ 
When the peptides are supposed to modify the downstream region of the Mother Part 
 
Then, the procedure for peptide modification SHOULD be as showed in Figure.3 or 
Figure.4. 
 
 
 
 
 
 
 
 
 
 
Figure.3 Prefix-Modification of Randomized Peptide Sequence 
EcoRI NotI XbaI SpeI NotI PstI Mother Part NgoMIV AgeI 
AgeI AgeI 
EcoRI NotI XbaI SpeI NotI PstI Daughter Part AgeI 
  
 
 
 
 
 
 
 
 
Figure.4 Suffix-Modification of Randomized Peptide Sequence 
 
For BioBricks that need further fusion, peptide sequences should be randomly generated 
as: 
                                                  NgoMIV                  AgeI 
5’-GCCGGC (NNN)n ACCGGT -3’ 
 
Then, the procedure for peptide modification SHOULD be as showed in Figure.5 or 
Figure.6. 
 
 
 
 
 
 
 
 
 
 
Figure.5 Prefix-Modification of Randomized Peptide Sequence for Further Fusion 
 
EcoRI NotI XbaI SpeI NotI PstI Mother Part NgoMIV AgeI 
NgoMIV NgoMIV 
EcoRI NotI XbaI SpeI NotI PstI Daughter Part NgoMIV 
EcoRI NotI XbaI SpeI NotI PstI Mother Part NgoMIV AgeI 
NgoMIV AgeI 
EcoRI NotI XbaI SpeI NotI PstI Daughter Part AgeI NgoMIV 
  
 
 
 
 
 
 
 
 
Figure.6 Suffix-Modification of Randomized Peptide Sequence for Further Fusion 
 
8. Summary 
•  BBF RFC 46 is an extension of BBF RFC 25 and compatible with BBF RFC 10.  
•  It  makes large-scale peptide modification easier to manipulate. 
•  The  fusion  format  is  compatible  with  the  established  BioBrick  cloning  protocols 
preserving standard restriction sites of prefix and suffix. 
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